Brain Scientific Inc. (BRSF)
OTCMKTS: BRSF · Delayed Price · USD
0.750
0.00 (0.00%)
Aug 8, 2023, 12:00 AM EDT - Market closed
Brain Scientific Revenue
Brain Scientific had revenue of $5.08K in the twelve months ending September 30, 2023, down -98.90% year-over-year. In the year 2022, Brain Scientific had annual revenue of $214.56K, a decrease of -19.26%.
Revenue (ttm)
$5.08K
Revenue Growth
-98.90%
P/S Ratio
183.46
Revenue / Employee
$462
Employees
11
Market Cap
931.99K USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2022 | 214.56K | -51.18K | -19.26% |
Dec 31, 2021 | 265.75K | 172.08K | 183.72% |
Dec 31, 2020 | 93.66K | -395.54K | -80.85% |
Dec 31, 2019 | 489.20K | 431.09K | 741.81% |
Dec 31, 2018 | 58.11K | 51.09K | 727.58% |
Dec 31, 2017 | 7.02K | - | - |
Dec 31, 2016 | 0 | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 371.62B |
Johnson & Johnson | 85.16B |
Merck & Co. | 60.12B |
AbbVie | 54.32B |
Novartis AG | 49.92B |
AstraZeneca | 47.61B |
Thermo Fisher | 42.86B |
Abbott Laboratories | 40.11B |
BRSF News
- 1 year ago - From Decibels to Dollars: Piezoelectric Materials Market to Flourish - GlobeNewsWire
- 1 year ago - Brainbox Validates NeuroCap(TM) In Testing Regimen; Adds Them to its Sports Medicine and Pharma Solutions - GlobeNewsWire
- 1 year ago - Brain Scientific Partners with SysteMedic, Receives First Purchase Order for NeuroCaps in Israel - GlobeNewsWire
- 1 year ago - Brain Scientific Signs Agreement with MVAP Medical Supplies to Go After Rapidly Growing Pediatric Neurodiagnostic Space - GlobeNewsWire
- 1 year ago - Brain Scientific Inks Deal with Fulcrum to Go After At-Home Diagnostic Space, Hires VP of Marketing and Communications - GlobeNewsWire
- 1 year ago - Brain Scientific Announces Release of Improved NeuroCap(TM) and New US Distribution Deal with D&D Medical - GlobeNewsWire
- 1 year ago - Daniel Cloutier, a Veteran Sales Executive, Joins Brain Scientific as Chief Revenue Officer - GlobeNewsWire
- 1 year ago - Brain Scientific Announces CE Mark Approval for NeuroCap™ Device - GlobeNewsWire